When did MARAVAI LIFESCIENCES HLDGS-A (MRVI) report earnings last quarter?
MARAVAI LIFESCIENCES HLDGS-A (MRVI) last reported earnings on 2/25/2026.
MARAVAI LIFESCIENCES HLDGS-A (MRVI) Earnings History & Surprises
NASDAQ:MRVI • US56600D1072
Current stock price
2.88 USD
+0.02 (+0.7%)
At close:
2.88 USD
0 (0%)
After Hours:
MRVI Earnings overview
Past quarterly earnings results for MARAVAI LIFESCIENCES HLDGS-A (MRVI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 54M
Last Reported
Most Recent- Release Date
- Feb 25, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.04
- EPS Surprise
- 44.70%
- Revenue Surprise
- -0.32%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.04 | -0.07 | 44.70% | 33.33% | 49.866M | 50.028M | -0.32% | -11.83% |
| Q3 2025 | -0.08 | -0.08 | 3.93% | -300.00% | 41.63M | 49.983M | -16.71% | -36.15% |
| Q2 2025 | -0.08 | -0.07 | -10.61% | - | 47.397M | 48.314M | -1.90% | -35.43% |
| Q1 2025 | -0.08 | -0.07 | -9.80% | -300.00% | 46.85M | 44.889M | 4.37% | -27.00% |
| Q4 2024 | -0.06 | -0.04 | -47.06% | -700.00% | 56.558M | 58.491M | -3.30% | -23.72% |
| Q3 2024 | -0.02 | -0.01 | -154.98% | -100.00% | 65.2M | 68.906M | -5.38% | -2.49% |
| Q2 2024 | 0.00 | 0.00 | -100.00% | - | 73.4M | 73.067M | 0.46% | 6.51% |
| Q1 2024 | -0.02 | -0.03 | 22.99% | -166.67% | 64.179M | 61.759M | 3.92% | -18.79% |
| Q4 2023 | 0.01 | -0.01 | 182.94% | -97.14% | 74.141M | 65.667M | 12.90% | -63.78% |
| Q3 2023 | -0.01 | 0.01 | -254.15% | -102.70% | 66.865M | 77.034M | -13.20% | -65.05% |
| Q2 2023 | 0.00 | 0.01 | -100.00% | -100.00% | 68.914M | 72.548M | -5.01% | -71.61% |
| Q1 2023 | 0.03 | 0.04 | -18.86% | -94.44% | 79.025M | 81.315M | -2.82% | -67.65% |
| Q4 2022 | 0.35 | 0.35 | 0.38% | -22.22% | 204.7M | 209.03M | -2.07% | -10.38% |
| Q3 2022 | 0.37 | 0.34 | 9.99% | -15.91% | 191.3M | 199.01M | -3.87% | -6.59% |
| Q2 2022 | 0.54 | 0.46 | 16.50% | 22.73% | 242.7M | 237.91M | 2.01% | 11.43% |
| Q1 2022 | 0.54 | 0.45 | 20.63% | 107.69% | 244.3M | 236.94M | 3.11% | 64.84% |
| Q4 2021 | 0.45 | 0.39 | 14.76% | 246.15% | 228.4M | 212.25M | 7.61% | 132.11% |
| Q3 2021 | 0.44 | 0.36 | 22.47% | - | 204.8M | 205.53M | -0.36% | 10.26% |
| Q2 2021 | 0.44 | 0.32 | 36.25% | - | 217.8M | 198.71M | 9.61% | - |
| Q1 2021 | 0.26 | 0.21 | 24.10% | - | 148.2M | 141.26M | 4.91% | - |
| Q4 2020 | 0.13 | 0.11 | 17.90% | - | 98.4M | 90.804M | 8.37% | - |
| Q3 2020 | - | - | 185.745M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
7.05%
Max EPS beat (4)
44.70%
Min EPS beat (4)
-10.61%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-3.64%
Max Revenue beat (4)
4.37%
Min Revenue beat (4)
-16.71%
Analysis
In the last 4 quarters, MRVI has beaten EPS estimates in 2 out of 4 releases
MRVI has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, MRVI has beaten the EPS estimates by 7.1% on average.
In the last 4 quarters, MRVI reported -3.6% below the revenue estimates on average.
Related analysis
MARAVAI LIFESCIENCES HLDGS-A / MRVI Earnings FAQ
Did MRVI stock beat earnings estimates in the most recent quarter?
MARAVAI LIFESCIENCES HLDGS-A (MRVI) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often MARAVAI LIFESCIENCES HLDGS-A beats earnings estimates?
In the last 4 quarters, MARAVAI LIFESCIENCES HLDGS-A (MRVI) has beaten EPS estimates in 2 out of 4 releases.